Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Science Bulletin
|
October 8, 2025
Single-cell omics analysis reveals tumor microenvironment rewiring after arsenic trioxide therapy in acute promyelocytic leukemia
Gang Xu, Jiyu Guo, Shengjin Fan, et al.
Biomaterials Science
|
December 1, 2022
All-in-one CoFe<sub>2</sub>O<sub>4</sub>@Tf nanoagent with GSH depletion and tumor-targeted ability for mutually enhanced chemodynamic/photothermal synergistic therapy
Niping Chen, Yakun Wang, Yaoxun Zeng, et al.
Cancer Letters
|
July 5, 2024
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
May 22, 2023
Inhibiting Osteolytic Breast Cancer Bone Metastasis by Bone-Targeted Nanoagent via Remodeling the Bone Tumor Microenvironment Combined with NIR-II Photothermal Therapy
Yaoxun Zeng, Zhenxing Pan, Jiongpeng Yuan, et al.
Cell Reports
|
December 13, 2025
Multi-omics-guided characterization of neoantigens improves patient stratification and potentiates combinatorial immunotherapy in glioma
Yingying Ma, Yangyang Cai, Jiaxin Yang, et al.
Cellular Signalling
|
April 7, 2023
The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development
Zefeng Chen, Dexu Ren, Jinyu Lv, et al.
JACS Au
|
December 26, 2025
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders
Yuan Ma, Gubu Amu, Yufei Pan, et al.
Molecular Therapy. Nucleic Acids
|
March 6, 2024
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential
Amu Gubu, Yuan Ma, Sifan Yu, et al.
Cell Death & Disease
|
February 4, 2023
VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression
Jing Ji, Yuxin Xu, Mengru Xie, et al.
Cell Reports. Medicine
|
April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer
Meiheng Sun, Hang Luo, Shuangying Qiao, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Science Bulletin
|
October 8, 2025
Single-cell omics analysis reveals tumor microenvironment rewiring after arsenic trioxide therapy in acute promyelocytic leukemia
Gang Xu, Jiyu Guo, Shengjin Fan, et al.
Biomaterials Science
|
December 1, 2022
All-in-one CoFe<sub>2</sub>O<sub>4</sub>@Tf nanoagent with GSH depletion and tumor-targeted ability for mutually enhanced chemodynamic/photothermal synergistic therapy
Niping Chen, Yakun Wang, Yaoxun Zeng, et al.
Cancer Letters
|
July 5, 2024
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
May 22, 2023
Inhibiting Osteolytic Breast Cancer Bone Metastasis by Bone-Targeted Nanoagent via Remodeling the Bone Tumor Microenvironment Combined with NIR-II Photothermal Therapy
Yaoxun Zeng, Zhenxing Pan, Jiongpeng Yuan, et al.
Cell Reports
|
December 13, 2025
Multi-omics-guided characterization of neoantigens improves patient stratification and potentiates combinatorial immunotherapy in glioma
Yingying Ma, Yangyang Cai, Jiaxin Yang, et al.
Cellular Signalling
|
April 7, 2023
The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development
Zefeng Chen, Dexu Ren, Jinyu Lv, et al.
JACS Au
|
December 26, 2025
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders
Yuan Ma, Gubu Amu, Yufei Pan, et al.
Molecular Therapy. Nucleic Acids
|
March 6, 2024
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential
Amu Gubu, Yuan Ma, Sifan Yu, et al.
Cell Death & Disease
|
February 4, 2023
VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression
Jing Ji, Yuxin Xu, Mengru Xie, et al.
Cell Reports. Medicine
|
April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer
Meiheng Sun, Hang Luo, Shuangying Qiao, et al.
Page
of 11